Product Information
MICONAZOLE 3 200 MG VAG SUPP is a generic product labeled by Actavis Pharma, Inc., priced at $13.8865 per EA under NDC 00472173803. Its NADAC has been published 411 times since Jan 22, 2014.
FDA first approved this application on Nov 19, 1993. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Miconazole Nitrate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
200 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00472173803
Classification
Generic
Dosage Form
SUPPOSITORY
Route
VAGINAL
Effective Date
9/23/2026
Active Ingredients
MICONAZOLE NITRATEApproval Type
Generic (ANDA)
FDA Application
ANDA073508FDA Approved
11/19/1993
TE Code
AB
On Market Since
1/18/1995
Pharmacological Classes
Price Statistics
The NADAC for MICONAZOLE 3 200 MG VAG SUPP has been published 411 times since Jan 22, 2014, and over the history we have for it it has risen 4.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $13.8865 per EA |
|---|---|
| All-time high | $14.3825 (Nov 12, 2025) |
| All-time low | $10.4873 (Jul 17, 2024) |
| 52-week high | $14.3825 |
| 52-week low | $13.7059 |
| Median price | $12.3567 |
| Average price | $12.6421 |
| Largest weekly change | +12.1% (Sep 18, 2024) |
| Weeks tracked | 411 |
| Tracking since | Jan 22, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Miconazole Nitrate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Actavis Pharma, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Miconazole Nitrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Azole Antifungal class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MICONAZOLE 3 200 MG VAG SUPP?
The current National Average Drug Acquisition Cost (NADAC) for MICONAZOLE 3 200 MG VAG SUPP, manufactured by Actavis Pharma, Inc., is $13.8865 per EA (NDC 00472173803), effective Sep 30, 2026.
How has the price of MICONAZOLE 3 200 MG VAG SUPP changed over time?
Over the history we have for it, the NADAC for MICONAZOLE 3 200 MG VAG SUPP has risen 4.9%. It has been tracked across 411 weekly CMS publications since Jan 22, 2014.
What are the highest and lowest recorded NADAC prices for MICONAZOLE 3 200 MG VAG SUPP?
Since Jan 22, 2014, the NADAC for MICONAZOLE 3 200 MG VAG SUPP has ranged from a low of $10.4873 (Jul 17, 2024) to a high of $14.3825 (Nov 12, 2025), with a median of $12.3567 per EA.
Are there cheaper alternatives to MICONAZOLE 3 200 MG VAG SUPP?
No other NADAC-published product currently shares the active ingredient and strength of MICONAZOLE 3 200 MG VAG SUPP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MICONAZOLE 3 200 MG VAG SUPP?
MICONAZOLE 3 200 MG VAG SUPP (NDC 00472173803) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.